Indoco Remedies Limited has reported a 4.6% jump in its net revenues for the third quarter ended 31 December 2021 to INR3.49bn ($47m), on the back of its domestic business growth.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?